Healixa Inc. Announces Regional Distribution Agreement for Its Eternal Spring Deposition Water Harvester Technology
Healixa Inc. Announces Regional Distribution Agreement for Its Eternal Spring Deposition Water Harvester Technology
Huntington, NY, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Healixa Inc. (OTC: EMOR) ("Healixa" or the "Company") is proud to announce that the Company has entered into a Regional Distribution Agreement with Caribbean Resource Solutions LLC to enable sales and distribution for its Eternal Spring Deposition Water Harvester technology in 18 countries and territories within the Caribbean Basin.
紐約州亨廷頓,2024年2月6日(GLOBE NEWSWIRE)——Healixa Inc.(場外交易代碼:EMOR)(“Healixa” 或 “公司”)自豪地宣佈,該公司已與加勒比資源解決方案有限責任公司簽訂了區域分銷協議,允許其永恒泉沉積水收集器技術在加勒比盆地的18個國家和地區進行銷售和分銷。
This Regional Distribution Agreement is anticipated to begin generating sales and distribution for the Company's Eternal Spring Deposition Water Harvester technology in Aruba, Anguilla, Antigua and Barbuda, Barbados, Bonaire, the British Virgin Islands, Curaçao, Grenada, Guadeloupe, Martinique, Saba, Saint Barthélemy, Saint Kitts and Nevis, Saint Lucia, Saint Martin, Sint Eustatius, Sint Maarten, and Trinidad and Tobago.
該區域分銷協議預計將開始在阿魯巴、安圭拉、安提瓜和巴布達、巴巴多斯、博內爾島、英屬維爾京群島、庫拉索島、格林納達、瓜德羅普島、馬提尼克島、薩巴、聖巴泰勒米、聖基茨和****斯、聖盧西亞、聖馬丁島、聖尤斯特歇斯島、聖馬丁島以及特立尼達和多巴哥銷售和分銷公司的永恒泉沉積水收集器技術。
As noted in the Company's press release on January 12, 2024, the initial deployment of the ES1 model successfully harvested 500 liters of water in less than 24 hours, operating in an environment with an average relative humidity of 45%. With far higher absolute humidity in all 18 aforementioned countries and territories, the Company anticipates that its Eternal Spring Deposition Water Harvester technology will outperform expectations in the Caribbean region.
正如該公司在2024年1月12日的新聞稿中指出的那樣,ES1模型的初始部署在不到24小時的時間內成功採集了500升水,在平均相對溼度爲45%的環境中運行。由於上述所有18個國家和地區的絕對溼度要高得多,該公司預計其****沉積水收集器技術在加勒比地區的表現將超過預期。
While these 18 aforementioned countries and territories are all islands surrounded by water, the Company believes that there is and will be a growing demand for alternatives to desalination and precipitation collection systems that are currently available.
儘管上述18個國家和地區都是被水環繞的島嶼,但該公司認爲,對目前可用的海水淡化和降水收集系統的替代品的需求不斷增長。
As stated by the Pan American Health Organization, the Regional Office for the Americas of the World Health Organization, "in addition to hurricanes, coastal flooding and rising sea levels can cause salt water to contaminate freshwater sources, making it difficult for people to access potable water sources. Water scarcity caused by climate-induced dry periods also leads to decreased hygiene and sanitation practices that exacerbate the spread of waterborne and foodborne illnesses.
正如世界衛生組織美洲區域辦事處泛美衛生組織所指出的那樣,“除颶風外,沿海洪水和海平面上升可能導致鹽水污染淡水源,使人們難以獲得飲用水源。氣候引起的乾旱期造成的水資源短缺也導致個人衛生和環境衛生習慣的降低,加劇了水源性和食源性疾病的傳播。
"This Caribbean market will undoubtedly become a major revenue center for the Company's Eternal Spring Deposition Water Harvester technology," stated Ian Parker, CEO of Healixa. "The technology's ability to steadily produce hundreds of liters of water per day per unit remotely without access to municipal water utilities will prove to be a tremendous asset to commercial, governmental, humanitarian, and residential applications in the Caribbean region."
Healixa首席執行官伊恩·帕克表示:“這個加勒比海市場無疑將成爲該公司永恒彈簧沉積水收集器技術的主要收入中心。”“該技術能夠在不使用市政供水設施的情況下每天遠程穩定地生產數百升水,這將是加勒比地區商業、政府、人道主義和住宅應用的巨大資產。”
About Healixa, Inc.
關於 Healixa, Inc.
Healixa, Inc. (OTC: EMOR) is a pioneering technology company that specializes in developing and acquiring disruptive technologies in clean water generation, health-tech, and green-tech sectors. By leveraging a combination of intellectual properties, patents, strategic alliances, and partnerships, Healixa has created a "LaunchPad" for innovative and sustainable products. For more information, please visit .
Healixa, Inc.(場外交易代碼:EMOR)是一家開創性的科技公司,專門開發和收購清潔水發電、健康科技和綠色科技領域的顛覆性技術。通過綜合利用知識產權、專利、戰略聯盟和合作夥伴關係,Healixa爲創新和可持續產品創建了 “LaunchPad”。欲了解更多信息,請訪問。
Safe Harbor Statement
安全港聲明
Certain statements contained in this press release may constitute forward-looking statements. These forward-looking statements are based on current expectations of management and are subject to significant risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, the progress, timing, cost, and results of partnerships and product development programs, as well as difficulties or delays in obtaining regulatory approval or patent protection. Healixa, Inc. undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
本新聞稿中包含的某些陳述可能構成前瞻性陳述。這些前瞻性陳述基於管理層當前的預期,存在重大風險和不確定性,可能導致實際業績與前瞻性陳述中描述的結果存在重大差異。這些風險和不確定性包括但不限於合作伙伴關係和產品開發計劃的進展、時機、成本和結果,以及在獲得監管批准或專利保護方面的困難或延遲。Healixa, Inc. 沒有義務公開發布對這些前瞻性陳述的任何修訂,以反映本聲明發布之日之後的事件或情況,也沒有義務公開發布對這些前瞻性陳述的任何修訂,也沒有義務反映意外事件的發生。
Healixa Contact:
Healixa 聯繫人:
Bret Hedges
SVP of Strategic Partnerships
833-432-5492
Bret@healixa.com
Bret Hedges
戰略合作伙伴關係高級副總裁
833-432-5492
Bret@healixa.com
譯文內容由第三人軟體翻譯。